Biopharmaceutical Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Biopharmaceutical stocks.

Biopharmaceutical Stocks Recent News

Date Stock Title
Oct 1 BMY PRME Stock Rises 11.8% on Collaboration With Bristol Myers
Oct 1 BMY A schizophrenia win for BMS’ Cobenfy, but challenges lie ahead
Oct 1 BMY BMS and Prime ink potential $3.5bn deal to develop T cell therapies
Oct 1 BMY Read This Before Considering Bristol-Myers Squibb Company (NYSE:BMY) For Its Upcoming US$0.60 Dividend
Oct 1 EWTX Edgewise Therapeutics to Present on Sevasemten (EDG-5506) for Becker Muscular Dystrophy (Becker) at the 29th International Annual Congress of the World Muscle Society
Oct 1 BMY 5 FDA decisions to watch in the fourth quarter
Oct 1 BMY Bristol-Myers Squibb Company (BMY) is Driving Growth Through Strategic Acquisitions
Oct 1 BNTC Suvretta Capital Management's Strategic Acquisition in Benitec Biopharma Inc
Sep 30 BMY Bristol Myers gets $6.4B Celgene CVR case dismissed: report
Sep 30 BMY Sector Update: Health Care Stocks Advance Late Afternoon
Sep 30 BMY US Judge Dismisses $6.4 Billion Suit Against Bristol Myers Over Delay in Drug Approvals
Sep 30 BMY Bristol Myers beats $6.4 billion lawsuit over delayed cancer drug
Sep 30 BMY Prime Medicine stock rallies 15% on Bristol Myers deal, drug updates
Sep 30 BMY Bristol, Prime Medicine in deal to develop T-cell therapies
Sep 30 BMY Company News for Sep 30, 2024
Sep 30 BMY Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines Pipeline
Sep 30 BMY Prime Medicine Announces Strategic Research Collaboration and License Agreement with Bristol Myers Squibb to Develop and Commercialize Multiple Prime Edited Ex Vivo T-Cell Therapies
Sep 30 BMY Prime to narrow gene editing research as it strikes deal with Bristol Myers
Sep 30 ELVN Enliven Therapeutics’ ELVN-001 shows promise in Phase I CML trial
Sep 28 BNTC Benitec Biopharma (NASDAQ:BNTC) Is In A Good Position To Deliver On Growth Plans
Biopharmaceutical

A biopharmaceutical, also known as a biologic(al) medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

Browse All Tags